Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

2018 marks the 10 year anniversary since the Journal of Hematology & Oncology published its first article. Over the past decade, the journal has established itself in the top quartile of journals in both its fields worldwide.

To mark this occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 10 years.

Content type: Letter to the Editor
| 24 September 2018

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis

Authors: Stephen Couban, Giulia Benevolo, William Donnellan, Jennifer Cultrera, Steffen Koschmieder, Srdan Verstovsek, Gregory Hooper, Christian Hertig, Maneesh Tandon, Natalie Dimier, Vikram Malhi and Francesco Passamonti
Content type: Review
| 24 September 2018

Cytokine release syndrome: grading, modeling, and new therapy

Authors: Delong Liu and Juanjuan Zhao
Content type: Research
| 19 September 2018

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

Authors: Marcia Bellon, Ramona Moles, Hassiba Chaib-Mezrag, Joanna Pancewicz and Christophe Nicot
Content type: Review
| 19 September 2018

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Authors: Guoshuang Shen, Fangchao Zheng, Dengfeng Ren, Feng Du, Qiuxia Dong, Ziyi Wang, Fuxing Zhao, Raees Ahmad and Jiuda Zhao
Content type: Review
| 17 September 2018

Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications

Authors: Min Su, Yuhang Xiao, Junliang Ma, Deliang Cao, Yong Zhou, Hui Wang, Qianjin Liao and Wenxiang Wang

Most recent articles RSS

View all articles

Content type: Review
| 22 March 2011

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Authors: Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
Content type: Review
| 10 June 2009

The effects of β-glucan on human immune and cancer cells

Authors: Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze
Content type: Review
| 25 February 2013

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Authors: Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang
Content type: Review
| 19 August 2013

Ibrutinib and novel BTK inhibitors in clinical development

Authors: Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu
Content type: Review
| 30 September 2013

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Authors: Li Shi, Shaohua Chen, Lijian Yang and Yangqiu Li

Most accessed articles RSS

View all articles

Featured series: Recent development in cancer immunotherapy

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Research highlights

Journal of Hematology & Oncology is now publishing research highlights – commentaries on recently published work that place the new research in the context of the current literature.

Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

Articles

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis

Cytokine release syndrome: grading, modeling, and new therapy

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

The effects of β-glucan on human immune and cancer cells

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Ibrutinib and novel BTK inhibitors in clinical development

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Featured series: Recent development in cancer immunotherapy

Aims and scope

Experimental Hematology & Oncology

Editor's quote

Research highlights

Official journal of

2017 Journal Metrics

Journal of Hematology & Oncology

Contact us